Eledon Pharmaceuticals Inc

NASDAQ:ELDN  
2.54
+0.08 (+3.46%)
4:40:11 PM EDT: $2.50 -0.04 (-1.58%)
Earnings Announcements

Eledon Pharmaceuticals Reports Third Quarter 2022 Operating, Financial Results

Published: 11/14/2022 21:47 GMT
Eledon Pharmaceuticals Inc (ELDN) - Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results.
Qtrly Loss per Share $0.73.
Q3 Earnings per Share View $-0.68 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.62

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.